Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Cell-mediated immunity may be more important than neutralizing antibodies in COVID-19 outcome

A new study sheds light on some important differences between asymptomatic and symptomatic patients with coronavirus disease 2019 (COVID-19).

23 Dec 2020

Study finds significantly lower mother-to-newborn transfer of anti-SARS-CoV-2 antibodies

Pregnant women may be especially vulnerable to developing more severe cases of COVID-19 following SARS-CoV-2 infection, but little is known about their anti-SARS-CoV-2 immune response or how it may affect their offspring.

22 Dec 2020

COVID-19 patients retain immunity against the virus for at least 8 months

Australian researchers have revealed - for the first time - that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.

22 Dec 2020

SARS-CoV-2 antibody levels and types differ by disease severity, study finds

Researchers have measured the antibody levels and types in hospitalized coronavirus disease 2019 (COVID-19) patients with different disease severity. Their results suggest gut immune pathways could play a role in reducing virus-based inflammation and recovery.

22 Dec 2020

Scientists isolate anti-COVID-19 nanobodies produced by a llama

National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or "nanobodies," against SARS-CoV-2 that were produced by a llama named Cormac.

22 Dec 2020

Large-scale study set up in UK to assess possibility of SARS-CoV-2 re-infection among healthcare workers

Researchers from Public Health England are conducting a large-scale prospective longitudinal study to determine whether healthcare workers who have previously developed coronavirus disease 2019 (COVID-19) are immune to reinfection with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Dec 2020

Research reveals development stages of plaques in Alzheimer's disease

One cannot simply look inside someone else’s head. This makes it difficult to understand what is happening in the brains of people with dementia. A new method offers insights.

21 Dec 2020

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

The onset of the current COVID-19 pandemic revealed the seventh known pathogenic human coronavirus, SARS-CoV-2.

21 Dec 2020

Detecting SARS-CoV-2 sequences in blood monocytes

A meeting with doctors from Wuhan presented a compelling observation to Professor Laura Manuelidis, MD, from the Yale Medical School early in 2020.

21 Dec 2020

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

Hospitalized COVID-19 patients have a greater risk of dying if they are men or if they are obese or have complications from diabetes or hypertension, according to a new study conducted by University of Maryland School of Medicine researchers.

18 Dec 2020

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States.

18 Dec 2020

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Antibody News and Research

Further Reading

Cell-mediated immunity may be more important than neutralizing antibodies in COVID-19 outcome

Study finds significantly lower mother-to-newborn transfer of anti-SARS-CoV-2 antibodies

COVID-19 patients retain immunity against the virus for at least 8 months

SARS-CoV-2 antibody levels and types differ by disease severity, study finds

Scientists isolate anti-COVID-19 nanobodies produced by a llama

Large-scale study set up in UK to assess possibility of SARS-CoV-2 re-infection among healthcare workers

Research reveals development stages of plaques in Alzheimer's disease

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

Detecting SARS-CoV-2 sequences in blood monocytes

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

Scientists demonstrate a promising strategy for treating lymphomas

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

Potency of neutralizing antibodies predicts COVID-19 severity and survival

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo